Increased brain concentration of homovanillic acid in rats treated with threo-3,4-dihydroxyphenylserine.
D000818:Animals; D001545:Benserazide / Q000494:pharmacology; D001923:Brain Chemistry / Q000187:drug effects*; D015103:Droxidopa / Q000494:pharmacology*; D006719:Homovanillic Acid / Q000378:metabolism*; D008297:Male; D009638:Norepinephrine / Q000378:metabolism; D010648:Phenylacetates / Q000378:metabolism*; D051381:Rats; D011919:Rats, Inbred Strains; D012694:Serine / Q000031:analogs & derivatives*
D010648:Phenylacetates; D012694:Serine; D001545:Benserazide; D015103:Droxidopa; D009638:Norepinephrine; D006719:Homovanillic Acid